![Xiang Gao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiang Gao
Founder at
GEMPHARMATECH CO., LTD.
Net worth: 1 111 M $ as of 30/09/2026
Profile
Dr. Xiang Gao is an Independent Non-Executive Director at China Huajun Group Ltd., an Independent Non-Executive Director at Alphamab Oncology and a Chairman at GemPharmatech Co., Ltd. He is on the Board of Directors at China Huajun Group Ltd. and Alphamab Oncology.
He received his undergraduate degree from Nanjing University, a graduate degree from Nanjing University and a doctorate degree from Thomas Jefferson University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/09/2026 | 196,417,185 ( 47.91% ) | 1 111 M $ | 30/09/2026 |
Xiang Gao active positions
| Companies | Position | Start |
|---|---|---|
| GEMPHARMATECH CO., LTD. | Founder | 29/12/2017 |
| ALPHAMAB ONCOLOGY | Director/Board Member | 30/06/2025 |
| CHINA HUAJUN GROUP LIMITED | Director/Board Member | 01/09/2026 |
Education of Xiang Gao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Huajun Group Ltd.
 China Huajun Group Ltd. Pulp & PaperProcess Industries Manufactures and prints printing, packaging and paper products | Process Industries |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GemPharmatech Co., Ltd.
 GemPharmatech Co., Ltd. BiotechnologyHealth Technology Specializing in the research and development of humanized models and drug screening technologies | Health Technology |
Alphamab Oncology
 Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Xiang Gao
